Fijolek Justyna, Wiatr Elzbieta, Piotrowska-Kownacka Dorota, Roszkowski-Sliz Kazimierz
The Third Department of Pneumonology and Oncology, National Tuberculosis and Lung Diseases Research Institute, Warsaw.
The First Department of Clinical Radiology, Independent Public Central Clinical Hospital of Medical University, Warsaw, Poland.
Multidiscip Respir Med. 2021 Nov 5;16(1):770. doi: 10.4081/mrm.2021.770. eCollection 2021 Jan 15.
Eosinophilia is rare but one of the important reasons to refer patients to pneumonological centers. Determining etiology of eosinophilia has practical implications for therapeutic intervention and disease prognosis. The study aimed to determine the role of peripheral eosinophilia in the diagnosis of lung disorders.
In this retrospective study were included 46 patients diagnosed with peripheral eosinophilia with coexisting respiratory symptoms and/or radiologically detected lung lesions. All patients underwent standard diagnostic procedures, including a detailed clinical history review, physical examination, routine laboratory tests with basal cardiological examinations, and serological tests to detect parasites and allergies. Other procedures carried out depended on the symptoms of each patient. The relation between eosinophil counts in the blood and patients' clinical manifestation was investigated to identify the degree of eosinophilia requiring immediate diagnostic procedures and treatment. Statistical analyses were performed using scientific computation libraries in the Python programming language, SciPy, v. 1.3.1. Briefly, the following tests were used: parametric Kruskal-Wallis H test, an independent t-test, ANOVA, the Shapiro- Wilk test, Fisher's and Chi-squared tests, and the Holm-Bonferroni method.
Severe eosinophilia (≥5,000 cells/μl) was associated with extrapulmonary involvement and constitutional symptoms. Skin, heart, and pleural diseases were more frequent in these patients than in patients with mild or moderate eosinophilia (p=0.010, p=0.040, and p=0.007, respectively), and only these patients showed signs of kidney disease (p=0.006). Vasculitis was significantly more frequent in the severe eosinophilia group (p=0.048) than in the other two groups. In patients with moderate eosinophilia (1,500-5,000 cells/μl), extrapulmonary symptoms were less common, although signs of cardiac involvement were confirmed in 44% of subjects. In this group, vasculitis was the most commonly observed disease (42% of cases). Mild eosinophilia (<1,500 cells/μl) was mainly associated with airway disease. In this group, vasculitis and interstitial lung diseases were identified, but most were not typically connected with eosinophilia.
Identification of peripheral eosinophilia may essentially determine diagnostic procedures in patients with lung disorders and may be a useful indicator of disease etiology.
嗜酸性粒细胞增多症较为罕见,但却是将患者转诊至肺病中心的重要原因之一。确定嗜酸性粒细胞增多症的病因对治疗干预和疾病预后具有实际意义。本研究旨在确定外周血嗜酸性粒细胞增多在肺部疾病诊断中的作用。
本回顾性研究纳入了46例诊断为外周血嗜酸性粒细胞增多且伴有呼吸道症状和/或影像学检查发现肺部病变的患者。所有患者均接受了标准诊断程序,包括详细的临床病史回顾、体格检查、基础心脏病学检查的常规实验室检查以及检测寄生虫和过敏的血清学检查。根据每位患者的症状进行其他检查。研究血液中嗜酸性粒细胞计数与患者临床表现之间的关系,以确定需要立即进行诊断程序和治疗的嗜酸性粒细胞增多程度。使用Python编程语言SciPy v. 1.3.1中的科学计算库进行统计分析。简而言之,使用了以下测试:参数化Kruskal-Wallis H检验、独立t检验、方差分析、Shapiro-Wilk检验、Fisher检验和卡方检验以及Holm-Bonferroni方法。
重度嗜酸性粒细胞增多(≥5,000个细胞/μl)与肺外受累和全身症状相关。与轻度或中度嗜酸性粒细胞增多的患者相比,这些患者的皮肤、心脏和胸膜疾病更为常见(分别为p = 0.010、p = 0.040和p = 0.007),并且只有这些患者出现了肾脏疾病的迹象(p = 0.006)。重度嗜酸性粒细胞增多组的血管炎明显比其他两组更常见(p = 0.048)。在中度嗜酸性粒细胞增多(1,500 - 5,000个细胞/μl)的患者中,肺外症状较少见,尽管44%的受试者证实有心脏受累迹象。在该组中,血管炎是最常观察到的疾病(42%的病例)。轻度嗜酸性粒细胞增多(<1,500个细胞/μl)主要与气道疾病相关。在该组中发现了血管炎和间质性肺疾病,但大多数与嗜酸性粒细胞增多无典型关联。
外周血嗜酸性粒细胞增多的识别可能从根本上决定肺部疾病患者的诊断程序,并且可能是疾病病因的有用指标。